0001792694-20-000002.txt : 20200327 0001792694-20-000002.hdr.sgml : 20200327 20200327165730 ACCESSION NUMBER: 0001792694-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200327 DATE AS OF CHANGE: 20200327 EFFECTIVENESS DATE: 20200327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Affinia Therapeutics Inc. CENTRAL INDEX KEY: 0001792694 IRS NUMBER: 833789975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-363863 FILM NUMBER: 20752632 BUSINESS ADDRESS: STREET 1: 100 BEAVER STREET CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 617-430-7817 MAIL ADDRESS: STREET 1: 100 BEAVER STREET CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: TDTx Inc. DATE OF NAME CHANGE: 20191030 D 1 primary_doc.xml X0708 D LIVE 0001792694 Affinia Therapeutics Inc. c/o Affinia Therapeutics Inc. 100 Beaver Street Waltham MA MASSACHUSETTS 02453 617-430-7817 DELAWARE TDTx Inc. Corporation true 2019 Rick Modi c/o Affinia Therapeutics Inc. 100 Beaver Street Waltham MA MASSACHUSETTS 02453 Executive Officer Director Luc Vandenberghe c/o Affinia Therapeutics Inc. 100 Beaver Street Waltham MA MASSACHUSETTS 02453 Director Sean Nolan c/o Affinia Therapeutics Inc. 100 Beaver Street Waltham MA MASSACHUSETTS 02453 Director Robert Johnson c/o Affinia Therapeutics Inc. 100 Beaver Street Waltham MA MASSACHUSETTS 02453 Executive Officer Robert Aboud c/o Affinia Therapeutics Inc. 100 Beaver Street Waltham MA MASSACHUSETTS 02453 Executive Officer David Grayzel c/o Affinia Therapeutics Inc. 100 Beaver Street Waltham MA MASSACHUSETTS 02453 Director Edward Mathers c/o Affinia Therapeutics Inc. 100 Beaver Street Waltham MA MASSACHUSETTS 02453 Director Robert Weisskoff c/o Affinia Therapeutics Inc. 100 Beaver Street Waltham MA MASSACHUSETTS 02453 Director Other Decline to Disclose 06b false 2020-03-12 false true false 0 68522920 38522942 29999978 false 16 0 0 0 false Affinia Therapeutics Inc. /s/ Rick Modi Rick Modi Chief Executive Officer 2020-03-27